Obstetric management of Rh immunization including intrauterine transfusion and immunotherapy.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000032:analysis; D000906:Antibodies / Q000032:analysis; D001663:Bilirubin / Q000032:analysis; D001805:Blood Transfusion, Intrauterine / Q000379:methods; D003131:Combined Modality Therapy; D005260:Female; D005865:Gestational Age; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D007116:Immunization, Passive; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007167:Immunotherapy; D010922:Placenta Diseases; D010956:Plasmapheresis; D011247:Pregnancy; D011248:Pregnancy Complications; D011398:Promethazine / Q000627:therapeutic use; D012203:Rh Isoimmunization / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D012204:Rh-Hr Blood-Group System / Q000276:immunology
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D012204:Rh-Hr Blood-Group System; D011398:Promethazine; D001663:Bilirubin